JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jellish, W. S.
Right arrow Articles by Slogoff, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jellish, W. S.
Right arrow Articles by Slogoff, S.
Anesth Analg 2000;91:1250-1255
© 2000 International Anesthesia Research Society


GENERAL ARTICLES

Recovery from Neuromuscular Blockade After Either Bolus and Prolonged Infusions of Cisatracurium or Rocuronium Using Either Isoflurane or Propofol-Based Anesthetics

W. Scott Jellish, MD, PhD, Michael Brody, MD, Kristina Sawicki, RN, and Stephen Slogoff, MD

Department of Anesthesiology, Loyola University Medical Center, Maywood, Illinois

Address correspondence and reprint requests to W. Scott Jellish, MD, PhD, Department of Anesthesiology, Loyola University Medical Center, 2160 South First Ave., Maywood, IL 60153. Address e-mail to wjellis{at}luc.edu

We examined the recovery characteristics of cisatracurium or rocuronium after bolus or prolonged infusion under either isoflurane or propofol anesthesia. Sixty patients undergoing neurosurgical procedures of at least 5 h were randomized to receive either isoflurane with fentanyl (Groups 1and 2) or propofol and fentanyl (Groups 3 and 4) as their anesthetic. Groups 1 and 3 received cisatracurium 0.2 mg/kg IV bolus, spontaneously recovered, after which time an infusion was begun. Groups 2 and 4 received rocuronium 0.6 mg/kg IV, spontaneously recovered, and an infusion was begun. Before the end of surgery, the infusion was stopped and recovery of first twitch (T1), recovery index, clinical duration, and train-of-four (TOF) recovery was recorded and compared among groups by using appropriate statistical methods. Clinical duration was shorter for rocuronium compared with cisatracurium using either anesthetic. Cisatracurium T1 75% recovery after the infusion was shorter with propofol compared with isoflurane. Cisatracurium TOF 75% recovery was similar after either bolus or infusion, but rocuronium TOF 75% recovery after the infusion was delayed. Infusion rates decreased for cisatracurium but remained relatively constant for rocuronium regardless of the anesthetic used. Isoflurane enhances the effect of both muscle relaxants but prolonged cisatracurium recovery more than rocuronium. Of the two muscle relaxants studied, rocuronium’s recovery was most affected by length of the infusion. Cisatracurium may be a more desired muscle relaxant for prolonged procedures because recovery was least affected by prolonged infusion.

Implications: This study describes the effect of different anesthetic techniques on the recovery of two different muscle relaxants, cisatracurium and rocuronium, when administered as either a single bolus or prolonged infusion during neurosurgery. This study demonstrates the feasibility of using these relaxants for these prolonged procedures.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
O. Kunitz, J.-H. Baumert, K. Hecker, T. Beeker, M. Coburn, A. Zuhlsdorff, and R. Rossaint
Xenon Does Not Prolong Neuromuscular Block of Rocuronium
Anesth. Analg., November 1, 2004; 99(5): 1398 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. S. Kim, M. A. Cheong, H. J. Lee, and J. M. Lee
Tactile Assessment for the Reversibility of Rocuronium-Induced Neuromuscular Blockade During Propofol or Sevoflurane Anesthesia
Anesth. Analg., October 1, 2004; 99(4): 1080 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. S. Breslin, K. Jiao, A. S. Habib, J. Schultz, and T. J. Gan
Pharmacodynamic Interactions Between Cisatracurium and Rocuronium
Anesth. Analg., January 1, 2004; 98(1): 107 - 110.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Amann, J. Rieder, M. Fleischer, P. Niedermuller, G. Hoffmann, A. Amberger, C. Marth, V. Nigrovic, and F. Puhringer
The Influence of Atracurium, Cisatracurium, and Mivacurium on the Proliferation of Two Human Cell Lines In Vitro
Anesth. Analg., September 1, 2001; 93(3): 690 - 696.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.